ALLMedicine™ Transferrin Saturation Center

May 18th, 2022 - The aim of this trial was to evaluate whether intravenous iron could provide benefit beyond transcatheter aortic valve implantation (TAVI) in iron deficient patients with severe aortic stenosis. In this randomised, placebo-controlled, double-blind...

May 2nd, 2022 - 1 Study populations 1.1) Study in patients with iron deficiency anemia with normal renal function. The study will be carried out in the serum samples of patients. All patients will be provided with the corresponding informed consent. Patients with...

Apr 25th, 2022 - This study examines factors associated with erythropoiesis-stimulating agent (ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new episodes, and variation across countries. We used international Dialysis Outcomes a...

Apr 21st, 2022 - This Phase III, randomized, double-blind, placebo-controlled, multicenter clinical study evaluated the safety and efficacy of ferumoxytol compared with placebo for the treatment of IDA, specifically in adult patients with IDA who have a history of...

Apr 6th, 2022 - Iron deficiency (ID) is very common in patients with solid tumors and may cause symptoms such as fatigue. However, its impact on clinical outcomes is poorly described. The aim of this prospective monocentric cohort study was to evaluate the evolut...

Aug 1st, 2021 - Increased serum ferritin is a very frequent cause of referral for which thorough evaluation is required to avoid unnecessary exploration and inaccurate diagnosis. Clinicians must thus know factors and tools that are relevant in this setting. Sever...

May 2nd, 2022 - 1 Study populations 1.1) Study in patients with iron deficiency anemia with normal renal function. The study will be carried out in the serum samples of patients. All patients will be provided with the corresponding informed consent. Patients with...

Apr 21st, 2022 - This Phase III, randomized, double-blind, placebo-controlled, multicenter clinical study evaluated the safety and efficacy of ferumoxytol compared with placebo for the treatment of IDA, specifically in adult patients with IDA who have a history of...

Mar 2nd, 2022 - Oral iron supplementation is the treatment of choice in patients with iron deficiency anemia. In several developing countries, including India, iron is routinely supplemented to pregnant women, especially during the second and third trimesters of ...

Feb 15th, 2022 - Health care structure analysis and recruitment (phase 1): In a first step, data on care facilities treating patients in the above indica-tions in Germany will be collected (gastroenterology, gynecology, hema-tology/oncology, and pneumology hospita...

Jul 19th, 2021 - Patients in maintenance treatment for HFE hemochromatosis since at least one year will be included in a two year study period and randomized in two groups experimental and control group. Because proton pump inhibitors are widely used as chronic me...

Feb 22nd, 2022 - A little over 3 years ago, researchers reported findings from PIVOTAL, the largest prospective, randomized trial to assess an aggressive versus conservative iron-repletion strategy in patients with end-stage kidney disease on hemodialysis, in The ...

Jan 25th, 2022 - There's overall agreement that iron deficiency is prevalent and portends a worse prognosis in patients with heart failure (HF), regardless of ejection fraction or anemia. What remains unclear, however, is which of the many definitions of iron defi...

Sep 29th, 2021 - Guidelines for the management of patients with iron deficiency anemia (IDA) in adults were published in September 2021 by the British Society of Gastroenterology (BSG) in Gut.[1] Assessment Before investigation, iron deficiency should be confirmed...

Jun 16th, 2020 - Proactive treatment with high-dose intravenous (IV) iron reduces the risk for classic atherothrombotic myocardial infarction — a type 1 MI — in dialysis patients, an analysis of data from the PIVOTAL trial shows. However, high-dose iron does not p...

Jun 16th, 2020 - Proactive treatment with high-dose intravenous (IV) iron reduces the risk for classic atherothrombotic myocardial infarction — a type 1 MI — in dialysis patients, an analysis of data from the PIVOTAL trial shows. However, high-dose iron does not p...